25 Extracorporeal shock wave therapy (ESWT) has been shown to induce different biological effects 26 on a variety of cells, including regulation and stimulation of their function and metabolism. ESWT 27 can promote different biological responses such as proliferation, migration, and regenerations of 28 cells. Recent studies have shown that mesenchymal stromal cells (MSCs) secrete factors that 29 enhance the regeneration of tissues, stimulate proliferation and differentiation of cells and decrease 30 inflammatory and immune-reactions. Clinically, the combination of these two therapies has been 31 used as a treatment for tendon and ligament lesions in horses; however, there is no scientific 32 evidence supporting this combination of therapies in vivo. Therefore, the objectives of the study 33 were to evaluate the effects of ESWT on equine umbilical cord blood mesenchymal stromal cells 34 (CB-MSCs) proliferative, metabolic, migrative, differentiation, and immunomodulatory 35 properties in vitro. Three equine CB-MSC cultures from independent donors were treated using 36 an electrohydraulic shock wave generator attached to a water bath. All experiments were 37 performed as triplicates. Proliferation, viability, migration and immunomodulatory properties of 38 the cells were evaluated. Equine CB-MSCs were induced to evaluate their trilineage differentiation 39 potential. ESWT treated cells had increased metabolic activity, showed positive adipogenic, 40 osteogenic, and chondrogenic differentiation, and showed higher potential for differentiation 41 towards the adipogenic and osteogenic cell fates. ESWT treated cells showed similar 42 immunomodulatory properties to none-ESWT treated cells. Equine CB-MSCs are responsive to 43 ESWT treatment and showed increased metabolic, adipogenic and osteogenic activity, but 44 unaltered immunosuppressive properties. In vivo studies are warranted to determine if synergistic 3 45 effects occur in the treatment of musculoskeletal injuries if ESWT and equine CB-MSC therapies 46 are combined. 47 Introduction 48 49 Extracorporeal shock wave therapy (ESWT) is one of the leading treatments of certain orthopedic 50 diseases in humans such as plantar fasciitis and lateral epicondylitis and more recently it has been 51 used to treat Achilles and patellar tendinopathies, [1, 2]. ESWT is also a common treatment for 52 tendon and ligament injuries in the horse particularly suspensory ligament desmitis [3]. At present, 53 it is also used in horses for osteoarthritis when other treatments are ineffective [4]. ESWT uses 54 acoustic waves generated mechanically outside of the body that can be focused to a specific point 55 within the body. Shock waves used for medical purpose are generated in a fluid medium, by one 56 of three different generators: electrohydraulic, piezoelectric or electromagnetic. The shape of the 57 acoustic wave is characterized by an initial positive rapid phase, of high amplitude, followed, by 58 a sudden phase of mild negative pressure, and then returns to the ambient values. Their peak 59 pressure is high -up to 100 mpa (500 bar) with a rapid rise (<10 ns) in pressure, of short duration 60 (<10 ms) and a broad range of frequency [5,6]. 61 62 A variety of cells in culture, including MSCs, have shown to be responsive to ESWT. Human bone 63 marrow stromal cells (hBMSCs) showed increased proliferation, migration and the rate of 64 apoptosis activation was reduced after treatment with focused ESWT, and all treated cells 65 maintained their differentiation potentials [7]. Rat adipose-derived stromal cells (ASCs) 66 responded to ESWT with an elevation of mesenchymal markers and a higher capacity to 67 differentiate towards adipogenic and osteogenic lineages with minimal changes in proliferation 4 68 [8]. When equine adipose tissue-derived mesenchymal stromal cells were treated with ESWT, they 69 showed increased proliferation, but no effects were observed in their differentiation potential [9]. 70 The increased proliferation after shockwave treatment may be mediated through purinergic 71 receptors via downstream ErK1/2 signals following activation by extracellular ATP [10]. 72 73 MSCs are multipotent cells capable of differentiation into osteogenic, adipogenic and 74 chondrogenic lineages [11]. Bone marrow aspirates and adipose tissue are the most studied and 75 used sources to obtain MSCs for clinical cases in the horse [12]. It has been suggested that MSCs 76 from umbilical cord blood (CB-MSCs) might have superior immune tolerance, proliferative 77 potential, and differentiation potency [13]. MSCs may function in two different ways, first in a 78 progenitor function by direct tissue integration and second in a non-progenitor function through 79 secretory products that have trophic and immunosuppressive effects [14]. Recent studies have 80 shown that MSCs secrete factors that enhance regeneration of injured tissue, stimulate proliferation 81 and differentiation of endogenous cells and decrease inflammatory and immune reactions [14-16]. 82 83 Clinically, the combination of ESWT and MSC therapies have been used as a treatment for tendon 84 and ligament lesions in horses without scientific evidence supporting this approach. We 85 hypothesized that ESWT will affect the progenitor functions and non-progenitor functions of 86 equine CB-MSCs. The aim of this study was to evaluate if ESWT affects equine CB-MSCs 87 proliferative, metabolic, migrative, differentiation, and immunomodulatory properties in vitro. 88 89 Material and methods 90 5 91 Culture of equine CB-MSCs and in vitro extracorporeal shock wave 92 treatment 93 94
12 251 days at 38°C in 5% CO 2 . After five days of co-culturing, cells were stained with 252 Bromodeoxyuridine (BrdU) and assessed with a BrdU ELISA kit (Roche, Mississauga, ON, 253 Canada) following the manufacturer's protocol. 254 255 Statistical Analysis 256 257 For statistical analysis, the effect of ESWT delivered on equine CB-MSCs was evaluated. A 258 statistical program (SAS 9.2, Proc MIXED, SAS Institute Inc., Cary, North Carolina, USA) was 259 used to fit a general linear mixed model. For proliferation, the design was a two-factor factorial in 260 a randomized complete block design with fixed effect factors treatment and passage. Interactions 261 were also included in the model. For metabolic activity, the data was divided by a million for 262 presentation. The design was also a two-factor factorial in a randomized complete block design 263 with fixed effect factor cell culture and treatment. For migration, the design was a two-factor 264 factorial in a randomized complete block design with fixed effect factors treatment and time. To 265 accommodate time being a repeated measure, the following correlation structures (offered by SAS) 266 were attempted: ar(1), arh(1), toep, toep(2)-toep(5), toeph toeph(2)-toeph(5) un un(2)-un(5), and 267 one was chosen based on Akaike Information Criterion (AIC). For adipogenesis, the design was a 268 two-factor factorial in a randomized complete block design by subsampling with fixed effect 269 factors cell culture and treatment. And for osteogenesis to accommodate time being a repeated 270 measure AIC was chosen. Repeated measures were nested in cell culture by treatment. Again, 271 these error structures were attempted: ar(1) arh(1) toep toep(2)-toep(4) toeph toeph(2)-toeph(4) un 272 un(2)-un(4). For the mononuclear cell suppression assay, a one-way ANOVA was performed with 273 Tukey's multiple comparisons test. Differences were considered significant at p ≤ 0.05. [21, 22] . Also, MSCs respond differently to the same stimulus, as 350 observed when human adult and neonatal cells from the same individual were induced for neuronal 351 transdifferentiation potential and showed different neuronal features [21] . Similarly, cells from the 352 umbilical cord blood have shown increased proliferation and potency compared to bone marrow 353 or adipose tissue [22] . As a result of this different response, a protocol utilizing the most 354 appropriate cell source and cell type is essential to obtain the best response to treatment with 355 ESWT.
356 357 In the current study, shock waves were applied via a water bath. The water bath was specifically 358 designed to allow propagation of the shock waves after passing the cell culture, as it has been 359 suggested that waves that are not propagated will get reflected at the culture medium and will 360 disrupt the upcoming waves as well as the cell monolayer [18] . Conflicting information about the 361 in vitro application of shock waves is published. Some authors recommend the application of the 362 shock waves to flasks with an MSC cell monolayer in a water bath as we reported here; while 363 others suggest applying shockwaves directly to tubes or flasks containing an MSC cell suspension 364 through an interface (water-cushion, pigskin) [7, 23] . The advantages of using the water bath in 365 this study standardizes conditions, like temperature and distance, as well as being a model that 366 simulates the in vivo conditions present during treatment with ESWT. One of the disadvantages of 367 the method we used in our study, is that some detachment of the cells in the monolayer can occur, 368 and furthermore, the cells located at the periphery might receive lower doses of ESWT [24] . 369 370 The beneficial effects of ESWT on wound healing have been shown on different species (25) .
371 Previous studies reported an increased expression in shockwave treated tissues of various growth 372 factors such as vascular endothelial growth factor (VEGF), transforming growth factor-beta 1 373 (TGF-B1) and insulin-like growth factor 1(IGF-1). The increase in growth factor levels is thought 374 to stimulate healing by increasing neovascularization, fibroblastic activity and proliferation 375 [25, 26] . Other studies in horses have shown no difference in overall healing time but significant 376 improved quality of healing by a decrease in granulation tissue [27] . Studies in vitro have shown 377 an increase in migration of hASC, as shown by the scratch assay, where treated cells filled the 378 scratch faster than the control [24] . We could not reproduce this finding in our study as we did not 379 see a difference in migration across the scratch after shockwave treatment. This reported difference 380 in biological behavior might be attributed to the distinct cell types or treatment protocols, as 381 previously mentioned. 382 383 We have shown that equine CB-MSCs maintain their multilineage differentiation potential after 384 treatment with ESWT. Treated cells do not only maintain but also increase their potency towards 385 adipogenic and osteogenic lineage. There is growing evidence suggesting that ESWT has an effect 386 on MSCs differentiation [7, 9, 10] . Until now, the only experiment assessing the response of equine 387 MSCs to ESWT reported that shock waves stimulate a higher potential for differentiation towards
